Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
SM1 invasionÀ» º¸ÀÎ Á¶±âÀ§¾ÏÀÇ ³»½Ã°æÄ¡·á¿¡ ³í¶õÀÌ ÀÖ½À´Ï´Ù. ºÐÈÁ¶Á÷Çü, 2cm ¹Ì¸¸, lymphatic (-)¶ó¸é SM1 cancer´Â ESD ÈÄ Ãß°¡ ¼ö¼ú ¾øÀÌ °æ°ú°üÂûÀ» ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±×·¯³ª ESD ÈÄ extragastric recurrence´Â ´ëºÎºÐ expanded indication ƯÈ÷ SM invasionÀÇ °æ¿ì¿¡ ¹ß»ýÇÏ¿´½À´Ï´Ù. µû¶ó¼ ÃÖ±Ù¿¡´Â 300um ÀÌ»ó ħÀ±µÈ SM invasionÀº ÁÖÀÇÇÏÀÚ´Â ÀÇ°ßÀÌ ÀÖ½À´Ï´Ù.
ESD¸¦ ÇÏ¿´°í ¾Æ·¡¿Í °°Àº °á°ú¿´½À´Ï´Ù. ¿©·¯ºÐÀº ¾î¶»°Ô ÇϽðڽÀ´Ï±î?
Stomach, ESD : Early gastric carcinoma
1. Location : antrum, lesser curvature
2. Gross type : EGC type IIc
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size of carcinoma : (1) longest diameter, 12 mm (2) vertical diameter, 8 mm
6. Depth of invasion : invades submucosa, (depth of sm invasion : 350 §) (pT1b)
7. Resection margin : free from carcinoma(N) safety margin : distal 11 mm, proximal 9 mm, anterior 24 mm, posterior 12 mm, deep 50 §
8. Lymphatic invasion : not identified(N)
9. Venous invasion : not identified(N)
10. Perineural invasion : not identified(N)
11. Microscopic ulcer : absent
12. Histologic heterogeneity: absent
°ú°Å¿¡´Â expanded criteria¿¡ ÇØ´çÇϱ⠶§¹®¿¡ ±×³É ¿Ü·¡¿¡¼ ¼³¸íÇÏ°í ÃßÀû°üÂûÀ» ±ÇÇÏ¿´½À´Ï´Ù. ±×·¯³ª SM invasionÀ̾ú°í °æ°ú°üÂûÇÏ´ø ȯÀÚ Áß ¾Æ·¡¿Í °°ÀÌ extragastric recurrence¸¦ º¸ÀΠȯÀÚµéÀ» °æÇèÇÏ¸é¼ ´Ù¼Ò Á¶½É½º·´°Ô Á¢±ÙÇÏ°í ÀÖ½À´Ï´Ù.
Áõ·Ê 7. M/D, 16mm, SM 400um. 17°³¿ù ÈÄ ¸²ÇÁÀý ÀüÀÌ ¹ß°ßµÇ¾î ¼ö¼ú
.
.
.
.
.
¹°·Ð ´ëºÎºÐ °í·É ȯÀÚÀÌ°í surgical mortality/morbidityµµ °í·ÁÇؾßÇϱ⠶§¹®¿¡ ´Ã °í¹ÎÀÔ´Ï´Ù. ÃÖ±Ù¿¡´Â ȯÀÚ¿¡¼ Çö»óȲÀ» °¡Àå ÃÖ´ëÇÑ ÀÚ¼¼È÷ ¼³¸íµå¸° ÈÄ 1ÁÖÀÏ ÈÄ ¿Ü·¡¿¡¼ ´Ù½Ã ³íÀÇÇÏ°í ÀÖ½À´Ï´Ù. ´ëºÎºÐ °æ°ú°üÂûÀ» ¿øÇϽñâ´Â ÇÏÁö¸¸ ±×·¡µµ ÃæºÐÇÑ Á¤º¸ÇÏ ÃµÃµÈ÷ »ý°¢ÇÒ ½Ã°£À» µå¸®´Â °ÍÀÌ µµ¸®¶ó°í »ý°¢ÇÕ´Ï´Ù.
³»½Ã°æ ½Ã¼ú ÈÄ ÃÖÁ¾ º´¸®°á°ú¸¦ È®ÀÎÇϱâ À§ÇÑ ¿Ü·¡ ¹æ¹®ÀÔ´Ï´Ù. ³»½Ã°æÀ¸·Î ÀýÁ¦ÇÑ Á¶Á÷¿¡ ´ëÇÑ º´¸®°á°ú¿¡¼´Â ¼¼Æ÷Çü, ±íÀÌ, ¹üÀ§, ¸²ÇÁ°ü/Ç÷°ü µîÀ» °üÂûÇÕ´Ï´Ù. ÃÖÁ¾ °á°ú¿¡ µû¸£¸é ´Ù¸¥ °ÍÀº Å« ¹®Á¦°¡ ¾ø´Âµ¥ ±íÀÌ¿¡ ÀÖ¾î¼ ¾ÏÀÌ Á¦1ÃþÀÎ Á¡¸·Ãþ¿¡ ±¹ÇѵǾî ÀÖÁö ¸øÇÏ°í, Á¡¸·ÇÏÃþ(À§º® 4Ãþ Áß Á¦ 2Ãþ)¿¡ Á¶±Ý (0.5 mm ÀÌÇÏ) ħÀ±µÇ¾î ÀÖ´Â °ÍÀ¸·Î ³ª¿Ô½À´Ï´Ù. È®´ëÀûÀÀÁõÀ̶ó°í ºÎ¸£´Â ¹üÀ§¿¡ ¼ÓÇÏ´Â »óȲÀÔ´Ï´Ù. Ç¥ÁØÀûÀÎ ÀûÀÀÁõÀ» ´Ù¼Ò ÃÊ°úÇÑ »óȲÀ̶ó´Â ÀǹÌÀÔ´Ï´Ù. ´Ù¼Ò ¾Ö¸ÅÇÑ °æ¿ìÀÔ´Ï´Ù. ¼ö¼úÇÏÁö ¾Ê°í °æ°ú°üÂûÀ» ÇÏ´Â °æ¿ì Àç¹ß·üÀº 5% ÀüÈÄ·Î º¸°í ÀÖ½À´Ï´Ù. À§³»¿¡ Àç¹ßÇÏ´Â °æ¿ìµµ ÀÖ°í µå¹°°Ô ¿ø°Ý ÀüÀ̸¦ º¸ÀÌ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.
¹°·Ð ¼ö¼úÀ» ÇÏ°Ô µÇ¸é Àç¹ß·üÀ» ¾à°£ ÁÙÀÏ ¼ö ÀÖ´Ù´Â ÀÇ°ßµµ ÀÖ½À´Ï´Ù¸¸ ¼ö¼úÀº ¼ö¼úÀÔ´Ï´Ù. À§¸¦ ÃÖ¼ÒÇÑ 2/3 Á¤µµ À߶ó¾ß ÇÏ°í ÁÖº¯ ¸²ÇÁÀý±îÁö ¹Ú¸®Çϱ⠶§¹®¿¡ ¼ö¼ú¿¡ µû¸¥ ÇÕº´Áõ°ú ¼ö¼ú ÈÄ »îÀÇ Áú ÀúÇϸ¦ ÇÔ²² °í·ÁÇØ¾ß ÇÕ´Ï´Ù. Àü½Å¸¶ÃëÀÇ À§Çèµµ ¹«½ÃÇÒ ¼ö ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ³»¿ëÀ» ¸ðµÎ Á¾ÇÕÇÒ ¶§, Áï ¼ö¼úÀÇ µæ°ú ½ÇÀ» °í·ÁÇÒ ¶§ ÇöÀç ¼ö¼úÀÌ ÁÁÀ»Áö °æ°ú°üÂûÀÌ ÁÁÀ»Áö ½±°Ô ´ÜÁ¤Çϱ⠾î·Á¿î Á¤µµÀÔ´Ï´Ù.
ÀúÈñ´Â ÃæºÐÈ÷ ¼³¸íÇÏ°í ȯÀÚÀÇ ÀÇ°ßÀ» Á¸ÁßÇÑ´Ù´Â ÀÔÀåÀÔ´Ï´Ù. ÀÌ·± °æ¿ì´Â º¸Åë »ý°¢ÇÒ ½Ã°£À» µå¸®°í ÀÖ½À´Ï´Ù. 1ÁÖÀÏ ÈÄ ¿Ü·¡¸¦ Àâ¾Æµå¸®°ÚÀ¸´Ï ÃæºÐÈ÷ »ý°¢ÇÑ ÈÄ ÀÇ°ßÀ» Áֽñ⠹ٶø´Ï´Ù.
1ÁÖÀÏ ÈÄ °æ°ú°üÂûÀ» °áÁ¤ÇϽøé Àΰø ±Ë¾çÀº ´Ù ¾Æ¹°¾ú´ÂÁö, ÀÜ·ùº´¼Ò´Â ¾ø´ÂÁö È®ÀÎÇϱâ À§ÇÏ¿© 2-3°³¿ù ÈÄ ³»½Ã°æ °Ë»ç¸¦ ÇÏ°í ÀÖ½À´Ï´Ù. Åð¿ø½Ã ÀÌ¹Ì ¿¹¾àµÇ¾î ÀÖÀ» °ÍÀÔ´Ï´Ù. ÀÌÈÄ´Â 3³â µ¿¾ÈÀº 6°³¿ù °£°ÝÀ¸·Î, ±× ÀÌÈÄ´Â °Ë»ç °£°ÝÀ» Á¶±Ý ´Ã¸®°í ÀÖ½À´Ï´Ù. °¡±ÞÀûÀ̸é 1³â Á¤µµ´Â º» º´¿ø¿¡¼ °Ë»ç¹ÞÀ¸½Ã±â ¹Ù¶ø´Ï´Ù. ±× ÀÌÈÄ´Â ¿øÇÏ½Ã¸é °¡±î¿î ÀÇ·á±â°üÀ¸·Î µÇÀÇ·Ú ¼Ò°ß¼¸¦ ÀÛ¼ºÇÏ¿© ¿Å°Üµå¸®°í ÀÖ½À´Ï´Ù. ½Ì°Ì°Ô µå½Ã°í ±ÕÇüµÇ°í °Ç°ÇÑ ½Ä»ýÈ°À» ±ÇÇÕ´Ï´Ù. ¼ú°ú ´ã¹è´Â ÁÁÁö ¾Ê½À´Ï´Ù.
º¸Åë 2´Þ Á¤µµ ¾àÀÌ ÇÊ¿äÇѵ¥ ³²Àº ¾àÀº ÃæºÐÇϽʴϱî?
Á¦°¡ ÀÚ¼¼È÷ ½á µÎ¾úÀ¸´Ï Àǹ«±â·ÏÀ» º¹»çÇÏ¿© Àо½Ã°í °¡Á·°£ Àß »óÀÇÇÏ½Ã¾î ´ÙÀ½ ÁÖ¿¡ ÀÇ°ßÀ» Áֽøé ÁÁ°Ú½À´Ï´Ù.
°èȹ: 1ÁÖÀÏ ÈÄ ¿Ü·¡
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.